Data

>

Latest News

New machine-learning approach could speed precision drug development
New machine-learning approach could speed precision drug development

January 15th 2025

The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.

Tempus AI unveils new generative AI tools for clinical care and research
Tempus AI unveils new generative AI tools for clinical care and research

January 14th 2025

AI-enabled CGM app shows promise for glycemic control, weight management
AI-enabled CGM app shows promise for glycemic control, weight management

January 10th 2025

Image credit: JHVEPhoto | stock.adobe.com
FDA and Workflow Services Detail First 100 Days of Data Collection Partnership

March 5th 2024

stock.adobe.com
CitiusTech Partners With Radical Imaging

August 7th 2023

Latest CME Events & Activities

More News

Shaman Megill Coriell Life Sciences

Q&A With Coriell Life Sciences’ Chief Science Officer, Jeffrey A. Shaman, PhD, MS, and Chief Executive Officer, Scott Megill

July 25th 2023

Shaman and Megill discuss Coirell’s new platform, GeneDose LIVE.

Marc Eigner

Using Behavioral Science to Improve Clinical Trials

April 26th 2023

Marc Eigner, executive chairman of the board at Datacubed, details the ways his company is improving clinical trials.

Craig Gravina

Q&A With Craig Gravina, CTO at ObvioHealth

March 22nd 2023

Clinical trials for digital therapeutics have unique problems when it comes to collecting data, especially regarding adherence and efficacy. Gravina speaks with MDT about a new API from ObvioHealth that works to solve these issues.

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science to detection, monitoring, and prevention of adverse effects with pharmaceutical product. Medical safety concept ©Joel bubble ben- stock.adobe.com.

The Changing Practice of Pharmacovigilance

March 15th 2023

PV is on the road to becoming a leader, not a follower, in leveraging drug lifecycle information for clinical trials and to inform clinical care

Delve Health, UW Medicine Collaborate on Type II Diabetes AI/ML Learning

Delve Health, UW Medicine Collaborate on Type II Diabetes AI/ML Learning

February 23rd 2023

AI-READI study will collect and release a flagship medical dataset intended to accelerate machine learning applications and generate novel hypotheses about Type 2 Diabetes Mellitus.

© 2025 MJH Life Sciences

All rights reserved.